Select Drug Profiles

FDA Approvals, In the News, Select Drug Profiles

FDA Grants Approval to Avapritinib for Patients with GIST

FDA Approvals, In the News, Select Drug Profiles

Recap of FDA Drug Approvals in 2019

FDA Approvals, In the News, Select Drug Profiles

Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma

Drug Updates, FDA Approvals, In the News, Select Drug Profiles

November 11, 2019 — Oncology News & Updates

FDA Approvals, In the News, Select Drug Profiles

October 28, 2019 – Oncology News & Updates

Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Select Drug Profiles

Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News

FDA Approvals, Multiple Myeloma, In the News, Select Drug Profiles

FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma

Select Drug Profiles

Eylea (Aflibercept), a VEGF Receptor Inhibitor, Receives New Indication for All Stages of Diabetic Retinopathy

Lilly Ostrovsky

Lilly Ostrovsky

Select Drug Profiles

Imbruvica (Ibrutinib) plus Gazyva (Obinutuzumab) First Chemotherapy-Free Combination Approved as First-Line Treatment for Patients with CLL or SLL

Lilly Ostrovsky

Lilly Ostrovsky

Select Drug Profiles

Mavenclad (Cladribine) First Short-Course Oral Therapy Approved for Relapsing-Remitting Multiple Sclerosis and Active Secondary Progressive Disease

Lilly Ostrovsky

Lilly Ostrovsky

2
3
4
5
6
7
8

Page 5 of 20
Results 41 - 50 of 200

SUBSCRIBE

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Special Print Editions

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.